Literature DB >> 7294769

Pharmacokinetics of cefamandole in osseous tissue.

R J Lunke, R H Fitzgerald, J A Washington.   

Abstract

The ability of cefamandole to cross osseous capillary membranes and its concentrations in interstitial fluid spaces are studied in canine cortical bone. Extraction studies were performed by using indicator dilution techniques and demonstrated that cefamandole readily traversed osseous capillary membranes. Volume-of-distribution studies demonstrated that cefamandole was distributed in the plasma and interstitial fluid spaces of cortical bone. There was a direct correlation between the calculated concentrations of cefamandole in the interstitial fluid spaces of bone and the simultaneous serum levels determined by bioassay in animals in which a steady-state equilibrium had been achieved. This suggests that the less expensive and more readily available serum bioassay technique is more useful than bone bioassays in monitoring the osseous concentrations of cefamandole.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7294769      PMCID: PMC181534          DOI: 10.1128/AAC.19.5.851

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  EFFECT OF SERUM BINDING ON THE DISTRIBUTION OF PENICILLINS IN THE RABBIT.

Authors:  C M KUNIN
Journal:  J Lab Clin Med       Date:  1965-03

2.  Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles.

Authors:  E M RENKIN
Journal:  Am J Physiol       Date:  1959-12

3.  Pharmacological studies with cefamandole in human volunteers.

Authors:  B R Meyers; B Ribner; S Yancovitz; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

4.  Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.

Authors:  M Barza; S Melethil; S Berger; E C Ernst
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

5.  A concurrent flow model for extraction during transcapillary passage.

Authors:  J B Bassingthwaighte
Journal:  Circ Res       Date:  1974-09       Impact factor: 17.367

6.  Determination of antibiotic levels in human bone. I. Gentamicin levels in bone.

Authors:  H Rosin; A M Rosin; J Krämer
Journal:  Infection       Date:  1974       Impact factor: 3.553

7.  Prediction of peak penicillin and cephalosporin concentrations in canine serum as derived from in vitro serum and tissue quantitative protein binding.

Authors:  L R Peterson; D N Gerding; D McLinn; W H Hall
Journal:  J Antimicrob Chemother       Date:  1979-03       Impact factor: 5.790

8.  Interaction of cephalosporins with human and canine serum proteins.

Authors:  L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1978-04       Impact factor: 5.226

9.  Concentration of cefamandole in serum interstitial fluid, bile, and urine.

Authors:  N G Waterman; H U Eickenberg; L Scharfenberger
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

10.  The transcapillary passage and interstitial fluid concentration of penicillin in canine bone.

Authors:  J D Bloom; R H Fitzgerald; J A Washington; P J Kelly
Journal:  J Bone Joint Surg Am       Date:  1980-10       Impact factor: 5.284

View more
  10 in total

Review 1.  Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

Review 2.  Anatomical barriers for antimicrobial agents.

Authors:  M Barza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

Review 3.  Osteomyelitis. Common causes and treatment recommendations.

Authors:  D R Dirschl; L C Almekinders
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

4.  Concentrations of ticarcillin and clavulanic acid in human bone after prophylactic administration of 5.2 g of timentin.

Authors:  D Adam; H D Heilmann; K Weismeier
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

Review 5.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 6.  Bone as an effect compartment : models for uptake and release of drugs.

Authors:  David Stepensky; Lilach Kleinberg; Amnon Hoffman
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Moxalactam penetration of normal and osteomyelitic bone.

Authors:  R H Fitzgerald
Journal:  Arch Orthop Trauma Surg       Date:  1983

8.  Aztreonam penetration into synovial fluid and bone.

Authors:  C M MacLeod; E A Bartley; J O Galante; L T Friedhoff; R Dhruv
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

9.  Bone penetration of amoxicillin and clavulanic acid evaluated by population pharmacokinetics and Monte Carlo simulation.

Authors:  Cornelia B Landersdorfer; Martina Kinzig; Jürgen B Bulitta; Friedrich F Hennig; Ulrike Holzgrabe; Fritz Sörgel; Johannes Gusinde
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

10.  Penetration of cefazolin into normal and osteomyelitic canine cortical bone.

Authors:  R C Daly; R H Fitzgerald; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.